App de análise facial ajuda a diagnosticar criança com doença rara

December 7, 2022

Metropolis – “Depois de 10 anos de busca e mais de 40 especialistas consultados, foi um aplicativo de reconhecimento facial que fechou a busca por um diagnóstico do menino Nicolas, de 13 anos. Usando o Face2Gene, da FDNA, o geneticista Carlos Leprevost inseriu uma fotografia do garoto e recebeu, em instantes, a informação que o menino tem uma doença genética rara chamada síndrome Coffin-Lowry.”

 

The article from Metropolis, emphasizes FDNA’s facial analysis app, Face2Gene, which played a crucial role in diagnosing a child with a rare genetic disease. This innovative app uses advanced facial analysis technology to examine patient photos, identifying key features associated with various genetic conditions. By comparing these features to a comprehensive database, Face2Gene provides quick and accurate diagnostic suggestions. This technology significantly aids healthcare professionals in making early and precise diagnoses. FDNA’s facial analysis app exemplifies the transformative power of AI in healthcare, offering a more efficient and accessible way to diagnose rare genetic disorders and improve patient outcomes.

Read More

Share this article

Most popular news

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading